Coronary angioplasty guide line - Taiwan Registration 5f7c3746d92b63ab469904a8944a1e0d

Access comprehensive regulatory information for Coronary angioplasty guide line in Taiwan's medical device market through Pure Global AI's free database. is registered under number 5f7c3746d92b63ab469904a8944a1e0d and manufactured by USCI DIVISION C.R. BARD, INC.. The authorized representative in Taiwan is SEAN K. FU & CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.